-
1 Comment
Avidity Biosciences, Inc is currently in a long term downtrend where the price is trading 12.5% below its 200 day moving average.
From a valuation standpoint, the stock is 94.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 71.5.
Avidity Biosciences, Inc's total revenue rose by 48.2% to $2M since the same quarter in the previous year.
Its net income has dropped by 56.5% to $-16M since the same quarter in the previous year.
Finally, its free cash flow fell by 160.5% to $-13M since the same quarter in the previous year.
Based on the above factors, Avidity Biosciences, Inc gets an overall score of 2/5.
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US05370A1088 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | 4B |
|---|---|
| PE Ratio | None |
| Target Price | 66.6923 |
| Beta | 1.01 |
| Dividend Yield | None |
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's product candidate Delpacibart etedesiran is for the treatment of myotonic dystrophy type 1 and is currently in phase 3 trial. Its other products in pipeline include Delpacibart zotadirsen for the treatment of duchenne muscular dystrophy, which is under phase 2 clinical development trial; and Delpacibart braxlosiran for the treatment of facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare genetic cardiomyopathies for PRKAG2 syndrome and PLN cardiomyopathy. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for RNA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
